Clearance Summary
Invitae Common Hereditary Cancers Panel received FDA 510(k) clearance under submission number DEN210011, sponsored by Invitae Corporation. The device was reviewed via the Direct premarket notification pathway and assigned to the Pathology review panel. The statutory decision date of record is 2023-09-29.
- Submission: DEN210011
- Applicant / Sponsor: Invitae Corporation
- Clearance pathway: Direct
- Review panel: Pathology
- Device class: Class II
- Regulation citation: 21 CFR 866.6095
- Decision date: 2023-09-29
Classification & Regulation
This clearance is catalogued under FDA product code QVU and 21 CFR 866.6095, within the Pathology review panel as a Class II device.